Carmela
Gómez Rodríguez
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Virgen del Rocío (2)
2024
-
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury
Spinal Cord, Vol. 62, Núm. 8, pp. 454-467
2022
-
Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia
Cancers, Vol. 14, Núm. 16